
### [NCIT:C3720](http://purl.obolibrary.org/obo/NCIT_C3720)
**Label:** Anaplastic Large Cell Lymphoma

**Subclasses:** [NCIT:C7208](http://purl.obolibrary.org/obo/NCIT_C7208) (Small Cell Variant Anaplastic Large Cell Lymphoma), [NCIT:C8658](http://purl.obolibrary.org/obo/NCIT_C8658) (Refractory Anaplastic Large Cell Lymphoma), [NCIT:C8659](http://purl.obolibrary.org/obo/NCIT_C8659) (Stage I Anaplastic Large Cell Lymphoma), [NCIT:C115357](http://purl.obolibrary.org/obo/NCIT_C115357) (Recurrent Childhood Anaplastic Large Cell Lymphoma), [NCIT:C5322](http://purl.obolibrary.org/obo/NCIT_C5322) (Central Nervous System Anaplastic Large Cell Lymphoma), [NCIT:C115032](http://purl.obolibrary.org/obo/NCIT_C115032) (Stage IV Childhood Anaplastic Large Cell Lymphoma), [NCIT:C115031](http://purl.obolibrary.org/obo/NCIT_C115031) (Stage III Childhood Anaplastic Large Cell Lymphoma), [NCIT:C115030](http://purl.obolibrary.org/obo/NCIT_C115030) (Stage II Childhood Anaplastic Large Cell Lymphoma), [NCIT:C9471](http://purl.obolibrary.org/obo/NCIT_C9471) (Childhood Systemic Anaplastic Large Cell Lymphoma), [NCIT:C39674](http://purl.obolibrary.org/obo/NCIT_C39674) (Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype), [NCIT:C37196](http://purl.obolibrary.org/obo/NCIT_C37196) (Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C9470](http://purl.obolibrary.org/obo/NCIT_C9470) (Systemic Anaplastic Large Cell Lymphoma), [NCIT:C37195](http://purl.obolibrary.org/obo/NCIT_C37195) (Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive), [NCIT:C9250](http://purl.obolibrary.org/obo/NCIT_C9250) (Recurrent Anaplastic Large Cell Lymphoma), [NCIT:C129599](http://purl.obolibrary.org/obo/NCIT_C129599) (Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C129598](http://purl.obolibrary.org/obo/NCIT_C129598) (Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive), [NCIT:C27366](http://purl.obolibrary.org/obo/NCIT_C27366) (Adult Systemic Anaplastic Large Cell Lymphoma), [NCIT:C27365](http://purl.obolibrary.org/obo/NCIT_C27365) (Adult Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C5636](http://purl.obolibrary.org/obo/NCIT_C5636) (Childhood Anaplastic Large Cell Lymphoma), [NCIT:C27367](http://purl.obolibrary.org/obo/NCIT_C27367) (Adult Anaplastic Large Cell Lymphoma), [NCIT:C115029](http://purl.obolibrary.org/obo/NCIT_C115029) (Stage I Childhood Anaplastic Large Cell Lymphoma), [NCIT:C6860](http://purl.obolibrary.org/obo/NCIT_C6860) (Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C7211](http://purl.obolibrary.org/obo/NCIT_C7211) (Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C37194](http://purl.obolibrary.org/obo/NCIT_C37194) (Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C8661](http://purl.obolibrary.org/obo/NCIT_C8661) (Stage III Anaplastic Large Cell Lymphoma), [NCIT:C37193](http://purl.obolibrary.org/obo/NCIT_C37193) (Anaplastic Large Cell Lymphoma, ALK-Positive), [NCIT:C8662](http://purl.obolibrary.org/obo/NCIT_C8662) (Stage IV Anaplastic Large Cell Lymphoma), [NCIT:C8660](http://purl.obolibrary.org/obo/NCIT_C8660) (Stage II Anaplastic Large Cell Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 53.75%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39740](http://purl.obolibrary.org/obo/NCIT_C39740) (Lung Inflammatory Myofibroblastic Tumor))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39739](http://purl.obolibrary.org/obo/NCIT_C39739) (Negative Peripheral Blood))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39725](http://purl.obolibrary.org/obo/NCIT_C39725) (Immunodeficiency))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39721](http://purl.obolibrary.org/obo/NCIT_C39721) (Abundance of Small Lymphocytes))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39720](http://purl.obolibrary.org/obo/NCIT_C39720) (Classical Reed-Sternberg Cell))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3972](http://purl.obolibrary.org/obo/NCIT_C3972) (Prostate Fibroma))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39719](http://purl.obolibrary.org/obo/NCIT_C39719) (PDGFRalpha Protein Overexpression))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39718](http://purl.obolibrary.org/obo/NCIT_C39718) (PDGFRA Gene Mutation))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39717](http://purl.obolibrary.org/obo/NCIT_C39717) (MDM2 Gene Mutation))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39716](http://purl.obolibrary.org/obo/NCIT_C39716) (EGFR Protein Overexpression))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39715](http://purl.obolibrary.org/obo/NCIT_C39715) (CD30-Positive Neoplastic Cells Present))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39712](http://purl.obolibrary.org/obo/NCIT_C39712) (KIT Gene Mutation))) 37.63%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39711](http://purl.obolibrary.org/obo/NCIT_C39711) (C-KIT Tyrosine Kinase Protein Overexpression))) 37.63%


